Podcast 1 Nov 2024
The immunometabolism landscape
To talk about immunometabolism, our guest on the podcast this week is CEO of Sitryx Therapeutics, Iain Kilty.
- Latest Posts
News and Trends 31 Oct 2024
Halloween biotech stories: Unveiling scientists’ worst fears
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
Best in Biotech 31 Oct 2024
Five T cell engager companies you should know about
Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.
In Depth 30 Oct 2024
Spatial Transcriptomics: A window into disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?
In Depth 30 Oct 2024
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
Best in Biotech 29 Oct 2024
GPCR therapies: Eight promising biotechs hacking the cell signaling pathway
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.
ADVERTISEMENT
ADVERTISEMENT
In Depth 25 Oct 2024
How biotech startups are trying to save the oceans with lab-grown fish
Find out everything you need to know about lab-grown fish, including the startups trying to save the oceans with their products.
Podcast 25 Oct 2024
Biotech beyond earth: The future of medicine in space
LinkGevity was selected for a NASA program for its potential to minimize the health and performance risks in human spaceflight. Find out more!
News and Trends 24 Oct 2024
Fighting severe epilepsies: A new era for Dravet syndrome treatment?
Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.
Best in Biotech 24 Oct 2024
Six biotech companies advancing multiple sclerosis therapies
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.
News and Trends 23 Oct 2024
RNA editing in humans: the race begins with first successful trial
Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space.
Best in Biotech 22 Oct 2024
Eight nanotechnology companies to watch out for
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.
ADVERTISEMENT
